European equities traded in the US as American depositary receipts were sharply higher late Tuesday morning, rising 2.1% to 1,351.12 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by furniture maker Natuzzi (NTZ) and accommodations booking company trivago (TRVG), which rose 5.2% and 4.9% respectively. They were followed by biopharmaceutical company Genfit (GNFT) and internet browser company Opera (OPRA), which were up 4.1% and 3.5% respectively.
The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and medical device maker EDAP TMS (EDAP), which fell 4.4% and 2.8% respectively. They were followed by telecommunications operator Telefonica (TEF) and pharmaceutical company Ascendis Pharma (ASND), which were down 1.4% and 1.2% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Bicycle Therapeutics (BCYC) and biotech firm Autolus Therapeutics (AUTL), which advanced 9.7% and 8.3% respectively. They were followed by biopharmaceutical companies Mereo BioPharma plc (MREO) and Adaptimmune Therapeutics (ADAP), which increased 5.2% and 5% respectively.
The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Akari Therapeutics (AKTX), which lost 4.7% and 4.3% respectively. They were followed by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and NuCana (NCNA), which dropped 2.1% and 1.2% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。